Hahn Capital Management LLC Embecta Corp. Transaction History

Hahn Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 17, 2023	SELL	$23.07 - $32.77 $41,226 - $58,559	-1,787 Reduced 15.91%	9,443 $266 Million
Q4 2022 Jan 25, 2023	SELL	$25.29 - $35.48 $5,614 - $7,876	-222 Reduced 1.94%	11,230 $284 Million
Q3 2022 Dec 06, 2022	BUY	$24.0 - $33.42 $8,376 - $11,663	349 Added 3.14%	11,452 $330 Million
Q2 2022 Aug 17, 2022	BUY	$24.78 - $33.36 $275,132 - $370,396	11,103 New	11,103 $281 Million

405

51.1M

162K

61K

Ticker EMBC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 57,836,500
Market Cap $1.17B
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...

Get notified when there are updates to the investment portfolio of Hahn Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Hahn Capital Management LLC with notifications on news.